BRCA2 and ovarian cancer: To estimate the actual prevalence of pathogenic/likely pathogenic germline indels, we carried out a systematic analysis of BRCA1 and BRCA2 tumour sequencing data at homopolymeric stretches, in a cohort of consecutive high-grade ovarian cancer (HGOC) patients.